Lu Kang Pharmaceutical: Intends to acquire 1.9231% equity of Hecheng Company.

Lu Kang Pharmaceutical Announcement: The company plans to acquire 1.9231% equity of Hecheng Company held by the Management Committee of Zoucheng Economic Development Zone through competitive bidding and delisting at Shandong Property Rights Trading Center. The final amount will be determined by the bidding result. After this transaction is completed, the company will directly hold 100% equity of Hecheng Company, and there will be no change in the scope of the company's consolidated financial statements. Hecheng Company's operating income for the year 2024 was 32.6304 million yuan, with a net profit of 28,700 yuan.